Mendus AB (publ) (STO:IMMU)
9.47
+0.47 (5.22%)
Aug 1, 2025, 5:29 PM CET
Chimerix Revenue
Mendus AB had revenue of 1.34M SEK in the quarter ending March 31, 2025, a decrease of -51.87%. This brings the company's revenue in the last twelve months to -1.44M, down -157.81% year-over-year.
Revenue (ttm)
-1.44M
Revenue Growth
-157.81%
P/S Ratio
-341.58
Revenue / Employee
-51.57K
Employees
28
Market Cap
493.24M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | - | - | - |
Dec 31, 2023 | - | - | - |
Dec 31, 2022 | 3.00M | 2.99M | 49,816.67% |
Dec 31, 2021 | 6.00K | - | - |
Dec 31, 2020 | - | - | - |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Swedish Orphan Biovitrum AB | 26.97B |
Sectra AB | 3.31B |
Getinge AB | 35.50B |
Camurus AB | 2.27B |
Medicover AB | 25.22B |
Asker Healthcare Group AB | 15.88B |
Bonesupport Holding AB | 1.06B |
AddLife AB | 10.44B |